ClinicalTrials.gg
CompletedNCT07935096Updated Nov 13, 2026

Effect of Nature-based Interventions on Mental Health and Markers of Inflammation in Women Victims of Violence Residing in the City of Bogotá

An interventional study of Nature-based interventions in Gender-Based Violence, Post-Traumatic Stress Disorder, PTSD and Anxiety, sponsored by Instituto Nacional de Salud, Colombia. Completed at 1 site in Colombia. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Instituto Nacional de Salud, Colombia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Apr 2025, registered Oct 2026).
Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

This study evaluates the effect of nature-based interventions on mental health and inflammation markers in women victims of gender-based violence living in Bogotá, Colombia. Participants were recruited with the support of the Centro de Promoción y Cultura of the Kennedy locality.

The intervention lasted four months and consisted of 14 weekly sessions, alternating between nature immersion therapy sessions, and horticulture activities supported by CityHuertas, so that each week participants attended one session of either modality.

Psychological outcomes including post-traumatic stress, anxiety, depression, and coping strategies were assessed using validated self-report scales (Davidson Trauma Scale, Beck Anxiety Inventory, Beck Depression Inventory-II, and Coping Strategies Inventory) at baseline and at four months. Biological outcomes include hair cortisol concentration, pro-inflammatory cytokines (GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, TNF-α), and immune cell proportions (T cells, B cells, and monocytes) measured by flow cytometry, also at both time points.

Read the detailed description

This quasi-experimental before-and-after study evaluated the effect of a four-month nature-based intervention on mental health outcomes and biological markers of inflammation in women victims of gender-based violence residing in Bogotá, Colombia. Participants were recruited with the support of the Centro de Promoción y Cultura of the Kennedy locality, with no age range restriction applied for eligibility.

The intervention consisted of 14 weekly sessions alternating between nature immersion therapy and horticulture activities. Nature immersion sessions took place in green spaces familiar to participants within their residential area, including a neighborhood park, the Humedal de la Vaca, Parque Timiza, and a final session at Parque EntreNubes. Horticulture sessions were carried out in a rooftop garden built at a facility belonging to the Centro de Promoción y Cultura of Kennedy, with the support of CityHuertas, where three raised garden beds were constructed for the intervention.

Psychological outcomes were assessed at baseline and post-intervention using four validated self-report instruments: the Davidson Trauma Scale (DTS) for post-traumatic stress symptoms, the Beck Anxiety Inventory (BAI), the Beck Depression Inventory-II (BDI-II), and the Coping Strategies Inventory (CSI). Biological samples were collected at both time points at a private space provided by the Centro de Promoción y Cultura, ensuring participant privacy. Blood samples were collected for quantification of ten pro-inflammatory cytokines (GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, and TNF-α) using a multiplex Luminex assay, and for determination of immune cell proportions (T cells, B cells, and monocytes) by flow cytometry. Hair samples were collected from the posterior vertex of the scalp for cortisol quantification by ELISA.

Comparisons between baseline and post-intervention values were performed using the Wilcoxon signed-rank test. Change scores for psychological parameters were calculated as post-intervention minus baseline values, and correlations between changes in psychological variables were assessed using Spearman's rank correlation test. To explore relationships between psychological outcomes and immunological biomarkers, principal component analysis (PCA) was conducted separately for soluble inflammatory markers and cellular immune parameters. Cytokine concentrations were log-transformed prior to PCA, and within-individual change scores were standardized. For cellular immune subsets, proportions were logit-transformed before calculating change scores. A multivariable generalized linear regression model was constructed to evaluate the association between immunological changes and a standardized global psychological change index derived from changes in depressive symptoms, anxiety, and post-traumatic stress symptoms, adjusting for age, duration of violence exposure, and lifetime exposure to single or multiple forms of violence. All analyses were conducted in R version 4.5.1, and figures were generated using R and GraphPad Prism version 8.0.2.

02

Conditions studied

  • Gender-Based Violence
  • Post-Traumatic Stress Disorder, PTSD
  • Anxiety
  • Depression Disorder
  • Chronic Inflammation
  • Immune System Dysregulation
  • Cortisol
  • Nature-based Interventions

Keywords

  • Violence against women
  • Anxiety
  • Depression
  • Cytokines
  • Stress
  • Nature-based interventions
03

In context

Combat Disorders

203 studies on the registry are indexed under Combat Disorders; 92 are open to participants now.

This study's enrollment of 30 is below the median of 72 across 170 interventional studies indexed under Combat Disorders.

Browse Combat Disorders studies →

Lead sponsor

This is the only study on the registry with Instituto Nacional de Salud, Colombia as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women victims of gender-based violence, including intimate partner violence, attempted femicide, armed conflict, trafficking, sexual abuse, and sexual exploitation.
  • Residents of Bogotá, Colombia.
  • Women with diverse sexual identities and orientations, including heterosexual women and those identifying as LGBTIQ+, as well as women living in conditions of extreme poverty.

Exclusion criteria

Exclusion Criteria:

- Women who had previously participated in psychosocial intervention programs developed by any governmental, private, or non-profit organization prior to recruitment into the present study.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Nature-based intervention

    14 weekly sessions over four months alternating between forest bathing and horticulture activities, delivered to all participants.

    Behavioral: Nature-based interventions

Interventions

  • BehavioralNature-based interventions

    Nature-based intervention combining two modalities delivered in 14 weekly sessions over four months, alternating between forest bathing and horticulture activities. Forest bathing sessions (Shinrin-yoku) consisted of slow-paced walks with guided mindful sensory exercises promoting conscious connection with the natural environment, including breathing exercises, tactile exploration of natural elements, and silent observation. These sessions took place in urban green spaces within the participants' residential area. Horticulture sessions involved the preparation of soil, sowing, transplanting, irrigation, and harvesting of vegetables and aromatic plants in a rooftop garden with three raised beds built at a facility of the Centro de Promoción y Cultura of the Kennedy locality, with technical support from CityHuertas.

06

What researchers measure

Primary outcomes

  1. Change in post-traumatic stress symptoms

    Change in post-traumatic stress symptoms assessed with the Davidson Trauma Scale (DTS), a 17-item self-report instrument evaluating frequency and severity of PTSD symptoms. Scores range from 0 to 136, with higher scores indicating greater symptom severity.

    Time frame: Baseline and 4 months

  2. Change in anxiety symptoms

    Change in anxiety symptoms assessed with the Beck Anxiety Inventory (BAI), a 21-item self-report instrument. Scores range from 0 to 63, with higher scores indicating greater anxiety severity.

    Time frame: Baseline and 4 months

  3. Change in depressive symptoms

    Change in depressive symptoms assessed with the Beck Depression Inventory-II (BDI-II), a 21-item self-report instrument. Scores range from 0 to 63, with higher scores indicating greater depression severity.

    Time frame: Baseline and 4 months

Secondary outcomes

  1. Change in pro-inflammatory cytokine concentrations

    Change in serum concentrations of ten cytokines (GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, TNF-α) quantified by multiplex Luminex assay, expressed in pg/mL.

    Time frame: Baseline and 4 months

  2. Change in immune cell proportions

    Change in proportions of T cells, B cells, and monocytes determined by flow cytometry.

    Time frame: Baseline and 4 months

  3. Change in hair cortisol concentration

    Change in cortisol concentration in hair samples collected from the posterior vertex of the scalp, quantified by ELISA, reflecting cumulative cortisol exposure over the intervention period.

    Time frame: Baseline and 4 months

07

Study locations

1 site
  • Instituto Nacional de Salud
    Bogotá, Bogota D.C. 111321, Colombia
08

References and documents

Publications

  • Luo H, Hu X, Liu X, Ma X, Guo W, Qiu C, Wang Y, Wang Q, Zhang X, Zhang W, Hannum G, Zhang K, Liu X, Li T. Hair cortisol level as a biomarker for altered hypothalamic-pituitary-adrenal activity in female adolescents with posttraumatic stress disorder after the 2008 Wenchuan earthquake. Biol Psychiatry. 2012 Jul 1;72(1):65-9. doi: 10.1016/j.biopsych.2011.12.020. Epub 2012 Feb 1. PubMed 22305287 ↗
  • Heller M, Roberts ST, Masese L, Ngina J, Chohan N, Chohan V, Shafi J, McClelland RS, Brindle E, Graham SM. Gender-Based Violence, Physiological Stress, and Inflammation: A Cross-Sectional Study. J Womens Health (Larchmt). 2018 Sep;27(9):1152-1161. doi: 10.1089/jwh.2017.6743. Epub 2018 Apr 9. PubMed 29630431 ↗
  • Kuffer A, Straus LD, Prather AA, Inslicht SS, Richards A, Shigenaga JK, Madden E, Metzler TJ, Neylan TC, O'Donovan A. Altered overnight levels of pro-inflammatory cytokines in men and women with posttraumatic stress disorder. Psychoneuroendocrinology. 2019 Apr;102:114-120. doi: 10.1016/j.psyneuen.2018.12.002. Epub 2018 Dec 5. PubMed 30544002 ↗
  • Wen Y, Yan Q, Pan Y, Gu X, Liu Y. Medical empirical research on forest bathing (Shinrin-yoku): a systematic review. Environ Health Prev Med. 2019 Dec 1;24(1):70. doi: 10.1186/s12199-019-0822-8. PubMed 31787069 ↗
  • Paredes-Cespedes DM, Velez N, Parada-Lopez A, Toloza-Perez YG, Tellez EM, Portilla C, Gonzalez C, Blandon L, Santacruz JC, Malagon-Rojas J. The Effects of Nature Exposure Therapies on Stress, Depression, and Anxiety Levels: A Systematic Review. Eur J Investig Health Psychol Educ. 2024 Mar 7;14(3):609-622. doi: 10.3390/ejihpe14030040. PubMed 38534901 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data will not be shared due to the sensitive nature of the information collected. Participants are women victims of gender-based violence, and disclosure of individual-level data could compromise their privacy, confidentiality, and safety. Data were collected under informed consent agreements that guarantee confidentiality and restrict use to the purposes of this study.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2025 to primary completion in Dec 2025, 8 months.

Of 75 non-industry interventional studies with no phase under Combat Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's 8 months is below that.

Counting every sponsor, half of 81 studies reached it within 25 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2026
First posted
Nov 13, 2026
StartActual
Apr 7, 2025
Primary completionActual
Dec 10, 2025
CompletionActual
Apr 7, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07935096
Lead sponsor
Instituto Nacional de Salud, Colombia
Collaborators
CityHuertas, Ministerio de Ciencia, Tecnología e Innovación
Responsible party
Diana Marcela Paredes Cespedes (Principal Investigator, Instituto Nacional de Salud, Colombia) — Principal investigator
First posted
Nov 13, 2026
Start date
Apr 7, 2025
Primary completion
Dec 10, 2025
Completion
Apr 7, 2026
Last update
Nov 13, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion